Investors

Investor information

BSE Scrip Code
539519
ISIN
INE280E01038
CIN
L51219MH1980PLC329224
Exchange
BSE Limited

The investment case

What a shareholder is buying.

01

A holding structure

Exposure to several operating businesses through one listed entity, rather than to a single product line or a single plant.

02

Acquired capability

Growth through businesses that already hold their licences and registrations, shortening the distance between capital deployed and revenue earned.

03

Evidence generated in-house

A planned bioequivalence centre would produce the study data the group's own export registrations depend on, and sell the same capacity to external sponsors.

04

Retained market access

Marketing authorisations held within the group where territories permit, so export revenue rests on registrations the group controls.

Corporate actions

Recent corporate actions

  • 22 July 2026 EOGM approved the change of name and alteration of the main objects clause.
  • 14 August 2026 Fresh Certificate of Incorporation issued by the Ministry of Corporate Affairs.
  • 20 August 2026 Change of name intimated to BSE Limited under Regulation 30 of SEBI LODR.